top of page
News
Search


Understanding Patient Experiences After Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases
Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.
Abdominal Cancers Alliance
Mar 10


March is Colorectal Cancer Awareness Month
Every March, during Colorectal Cancer Awareness Month , communities, clinicians, caregivers, and survivors come together to raise awareness about colorectal cancer—one of the most common cancers in the United States. While progress in prevention, screening, and treatment has saved lives, this disease remains a critical public health issue. What Is Colorectal Cancer? Colorectal cancer begins in the colon or rectum, which are parts of the lower digestive tract. It is one of the
Abdominal Cancers Alliance
Feb 25


When Cancer Comes Back: Lessons From CRS/HIPEC Research
Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis. (2026). Cancers. 18. 299. DOI: 10.3390/cancers18020299 . Understanding Recurrence After CRS/HIPEC for Colorectal Cancer Spread to the Abdomen When colorectal cancer spreads to the lining of the abdomen (called peritoneal metastasis ), one treatment option for carefully selected patients is cytoreductive surgery (CRS) com
Abdominal Cancers Alliance
Jan 26


A Combined Surgical Approach May Be an Option for Some People With Colorectal Cancer That Has Spread to the Abdomen and Liver
This research study explored outcomes for people with colorectal cancer that had spread to two places at the same time: the lining of the abdomen (called the peritoneum), and the liver.
Abdominal Cancers Alliance
Jan 2


Unlocking New Possibilities for Immunotherapy for Colorectal Cancers
This study focused on a key challenge: in many bowel cancers, especially stromal-rich types (those with lots of supporting tissue, or stromal cells, around the tumor), immune therapies aren’t working as well as hoped. Researchers investigated how certain “support” cells within the tumor (called stromal cells) may be actively helping the cancer by suppressing the body’s immune system. Then they investigated how to turn the immune system back on again in these hard-to-treat can
Abdominal Cancers Alliance
Oct 31, 2025


A Soldier's Journey to Survival
By Sonya Walker October 2025 (Col. Ret.) Dr. Lawrence Henry's journey is a testament to the power of resilience, self- advocacy, and...

Sonya Walker
Oct 8, 2025


I don't know how people feel about miracles, but it's a miracle.
By Christine Strovink New York May 2024 From video transcript: It started with an emergency. I had to have emergency surgery. They...
Abdominal Cancers Alliance
Sep 8, 2025




I don't think I'd have the life I have now
by Joe Finn September 23, 2023 Joe had some pains which prompted him to visit the hospital. There, he found out he had cancer. With some...
Abdominal Cancers Alliance
Sep 30, 2023


He said you are cancer free
by Paul Kalusa September 23, 2023 Paul was diagnosed with stage IV colon cancer two months after his daughter was born, but by finding...
Abdominal Cancers Alliance
Sep 23, 2023
Join us! Support our work today!
X
Do you have any suggestions for us? Your feedback is very valuable!
bottom of page
